Malibu Microbiome Meeting

Malibu Microbiome MeetingMalibu Microbiome MeetingMalibu Microbiome Meeting

Malibu Microbiome Meeting

Malibu Microbiome MeetingMalibu Microbiome MeetingMalibu Microbiome Meeting
  • Home
  • 2024 DETAILS
    • Save The Date
    • Agenda
    • Purchase Tickets
    • Prospectus
    • Sponsorship/Exhibit Info
  • PAST VIDEOS
  • CONTACT US
  • REVIEWS
  • PRESS
  • More
    • Home
    • 2024 DETAILS
      • Save The Date
      • Agenda
      • Purchase Tickets
      • Prospectus
      • Sponsorship/Exhibit Info
    • PAST VIDEOS
    • CONTACT US
    • REVIEWS
    • PRESS
  • Sign In

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • 2024 DETAILS
    • Save The Date
    • Agenda
    • Purchase Tickets
    • Prospectus
    • Sponsorship/Exhibit Info
  • PAST VIDEOS
  • CONTACT US
  • REVIEWS
  • PRESS

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

SESSION TOPICS

Microbiome 101

Speaker: Neil Stollman, MD (UCSF)

Objective: Become familiar with the human gut microbiome and its role in health.


Evidence of efficacy and safety of FMT for C. difficile infection

Speaker: Colleen Kelly, MD (Brown)

Objective: Review evidence from randomized controlled trials of FMT in C. difficile.


Unique Challenges Around Clinical Trials in C. difficile

Speaker: Paul Feuerstadt, MD (Yale)

Objective: Describe unique challenges to conducting clinical trials of microbiome-based therapies in C. difficile.


Taming the Wild West: Developing Standards for Microbiome Research and Product Development

Speaker: Scott Jackson, PhD (NIST)

Objective: Describe the importance of standards for microbiome measurements to support research investigations and clinical/commercial translation of microbiome science.


Detection of SARS-CoV-2 from patient fecal samples by WGS

Speaker: Andreas Papoutsis, PhD (ProgenaBiome)

Objective: Understand methods used to study the composition and function of the gut microbiome and identification of SARS-CoV-2.


Microbiome and Disease associations (cause or consequence)?

Speaker: Sabine Hazan, MD (ProgenaBiome)

Understand the value of genetic sequencing in fecal transplant and in SARS-CoV-2 therapies.


Microbiome based Therapies for Recurrent Urinary Tract Infections

Speaker: Sahil Khanna, MD (Mayo Clinic)

Objective: Examine the role of microbiome based therapy in chronic UTI.


Microbiota Transplant for Autism

Speaker: James B. Adams, PhD (Arizona State University)

Objective: Review a Phase 1 clinical trial of microbiota transplant for children with autism.


Management of Immunotherapy Induced Colitis

Speaker: Yinghong Wang, MD, PhD (MD Anderson)

Objective: Describe how gut microorganisms impact the metabolism of cancer therapies and how microbial manipulation may transform patient care.


Serendipity and Fecal Transplant

Speaker: Thomas Borody, MD (CDD Australia)

Objective: Explore Fecal transplant for other conditions beyond C.difffocusing on Crohn’s and neurological conditions.


Washed microbiota transplantation: Treatment beyond C.diffinfection

Speaker: Faming Zhang MD, PhD (Nanjing Medical University, Nanjing, China)

Objective: Describe the latest progress on methodology, safety and benefits related to FMT in conditions beyond C.diffinfection,


How do we move forward?

Speaker: Alexander Khoruts, MD (University of Minnesota)

Objective: Understand the challenges in doing research to develop and make available the next-generation microbiota therapeutics for different indications?


Panel Discussions,  Announcements, and more!  



Copyright © 2024 Malibu Microbiome Meeting - All Rights Reserved.